STTKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Shattuck Labs, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$5.37−0.05 (-0.92%)
Close on Oct 19, 2026
- Market cap
- $696.91M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$3.56 (+196.7%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Shattuck Labs, Inc. saw revenue fall 66.6% to $1.00M over the twelve months to Jun 30, 2026. Free cash flow was -$39.95M.
Revenue
$1.00M
-66.6% vs. a year earlier
Operating income
-$55.79M
TTM Q2 2026
Free cash flow
-$39.95M
FY2025
EPS, diluted
-$0.51
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $696.91M
- P/E ratio
- –
- Price to sales
- 696.91
- Price to book
- 3.30
- Dividend yield
- –
- Free cash flow yield
- -5.73%
Fundamentals
- Revenue
- $1.00M
- Net income
- -$52.57M
- EPS, diluted
- -$0.51
- Free cash flow
- -$39.95M
- Book value per share
- $1.63
- Diluted shares
- 130M
Eight years at a glance
Fiscal years 2018 to 2025 and trailing twelve months, USD
Revenue
$1.00M-66.6% YoY
Operating income
-$55.79M
Net income
-$52.57M
EPS, diluted
-$0.51
Free cash flow
–
Reported periodTrailing twelve months